Evidence map›Paper›PMID 30777112›Full record

Trial reportMalaria journal2019

Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia.

Fatou Jaiteh, Yoriko Masunaga, Joseph Okebe, Umberto D'Alessandro, Julie Balen, John Bradley, Charlotte Gryseels, Joan Muela Ribera, Koen Peeters Grietens

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Knowledge about Asymptomatic Malaria and Acceptability of UsingInternational journal of environmental research and public health · 2023
    Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 5 countries.

Fatou JaitehMedical Anthropology Unit, Institute of Tropical Medicine, Antwerp, Belgium. fjaiteh@mrc.gm.ORCID http://orcid.org/0000-0001-9712-295X
Yoriko MasunagaMedical Anthropology Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Joseph OkebeMedical Research Council Unit the Gambia at the London, School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Umberto D'AlessandroMedical Research Council Unit the Gambia at the London, School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Julie BalenSchool of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.
John BradleyLondon School of Hygiene and Tropical Medicine, London, UK.
Charlotte GryseelsMedical Anthropology Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Joan Muela RiberaPASS Suisse, Neuchâtel, Switzerland.
Koen Peeters GrietensMedical Anthropology Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Instituut voor Tropische Geneeskunde · BEMRC Unit the Gambia · GMLondon School of Hygiene & Tropical Medicine · GBObservatoire Cantonal de Neuchâtel · CHUniversity of Sheffield · GB

Funding

Medical Research Council MC_EX_MR/N006100/1Medical Research Council MR/K012126/1Medical Research Council MR/R010161/1
6 · The paper itself

Abstract

backgroundInnovative and cost-effective strategies that clear asymptomatic malaria infections are required to reach malaria elimination goals, but remain a challenge. This mixed methods study explored people's attitudes towards the reactive treatment of compound contacts of malaria cases with a 3-day course of dihydroartemisinin-piperaquine (DHAP), the socio-cultural representations of asymptomatic infections, and more specifically their treatment.

methodsPrior to the start of the intervention, a sequential mixed method study was carried out. Qualitative data collection involved in-depth interviews and participant observations (including informal conversations) with key informants from the trial communities and the trial staff. Quantitative data were derived from a pre-trial cross-sectional survey on health literacy and health-seeking behaviour among randomly selected members of the study communities.

resultsIn the pre-trial cross-sectional survey, 73% of respondents reported that malaria could be hidden in the body without symptoms. Whilst this may be interpreted as people's comprehension of asymptomatic malaria, qualitative data indicated that informants had different interpretations of asymptomatic disease than the biomedical model. It was described as: (i) a minor illness that does not prevent people carrying out daily activities; (ii) an illness that oscillates between symptomatic and asymptomatic phases; and, (iii) a condition where disease agents are present in the body but remain hidden, without signs and symptoms, until something triggers their manifestation. Furthermore, this form of hidden malaria was reported to be most present in those living in the same compound with a malaria case (71%).

conclusionTreating asymptomatic malaria with pharmaceuticals was considered acceptable. However, people felt uncertain to take treatment without screening for malaria first, largely due to the lack of symptoms. Knowledge of asymptomatic malaria was not a strong re-inforcement for treatment adherence. In this study, the pre-intervention active engagement of communities existed of having people co-design accurate information messages about their personal risk of malaria, which increased their trust in expert knowledge and thus proved essential for the successful implementation of the community-based intervention.

Indexed as

Asymptomatic InfectionsDisease EradicationPatient Acceptance of Health CareAdolescentAdultAntimalarialsArtemisininsChildChild, PreschoolCross-Sectional StudiesFemaleGambiaHumansInfantInfant, NewbornMalariaAntimalarialsArtemisininsartenimolpiperaquinePiperazinesQuinolinesAsymptomatic infectionCommunity perspectivesEliminationMalaria

Identifiers

PMID30777112
PMCPMC6378745
OpenAlexW2939375771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.